Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?
Acute disseminated encephalomyelitis: an evaluation of 15 cases in childhood.
Association of TNFAIP3 and TNFRSF1A variation with multiple sclerosis in a German case-control cohort.
Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.
Cardiac Sympathetic Hyperactivity in a Patient with Guillain-Barré Syndrome: An Analysis Using Cardiac [(123)I] Metaiodobenzylguanidine (MIBG) Scintigraphy.
The Emerging Roles of Gamma-Delta T Cells in Tissue Inflammation in Experimental Autoimmune Encephalomyelitis.
Patient-specific early classification of multivariate observations.
The antiviral drug ganciclovir does not inhibit microglial proliferation and activation.
[Emerging new disease--modifying therapies for multiple sclerosis].
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland.
Risk factors of early onset of MS in women in reproductive age period: survival analysis approach.
The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis.
Patient experience and practice trends in multiple sclerosis - clinical utility of fingolimod.
A novel internet-based method of capturing outcomes in multiple sclerosis.
MicroRNA Expression Aberration in Chinese Patients with Relapsing Remitting Multiple Sclerosis.
Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor.
Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.
Gyroscopic corrections improve wearable sensor data prior to measuring dynamic sway in the gait of people with Multiple Sclerosis.
Improved Detection of Cortical Gray Matter Involvement in Multiple Sclerosis with Quantitative Susceptibility Mapping.
Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland.
Tysabri® (natalizumab) data at ECTRIMS reaffirm positive effects of treatment for people with relapsing forms of MS
Axon growth inhibition by RhoA/ROCK in the central nervous system.
Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility.
Multiple sclerosis in Saudi Arabia: Anxiety, depression and suicidality.

Pages